FDA Adverse Event Other Summary report: N

FOUNDATION KNEE

MDR report key: 2851090 · Received November 19, 2012

Report

Report Number
1644408-2012-00624
Event Type
Other
Date Received
November 19, 2012
Date of Event
November 9, 2012
Report Date
November 9, 2012
Manufacturer
ENCORE MEDICAL, L.P.
Product Code
JWH
PMA / PMN Number
K923277
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS FORM IS ONLY TO REFLECT A CORRECTED LOT NUMBER.

Additional Manufacturer Narrative · 1

THE REASON FOR THIS REVISION SURGERY WAS TO REMEDY A WORN INSERT AFTER 7.7 YEARS OF PATIENT USE. THE OUTCOMES ATTRIBUTED TO THIS EVENT ARE NON-SERIOUS AND REQUIRED INTERVENTION TO PREVENT PERMANENT IMPAIRMENT/DAMAGE. THERE IS NO INFORMATION IN THIS COMPLAINT ABOUT ANY PATIENT INJURIES, ACTIVITIES, ACCIDENTS, OR MEDICAL CONTRAINDICATIONS THAT MAY HAVE CONTRIBUTED TO THE REVISION SURGERY. THERE WAS NO DELAY IN SURGERY AND ANOTHER SUITABLE DEVICE WAS AVAILABLE FOR USE. THE REVISION SURGERY WAS COMPLETED AS INTENDED. THE DEVICE WAS NOT RETURNED TO DJO SURGICAL FOR EXAMINATION. A REVIEW OF THE DEVICE HISTORY RECORDS SHOWED NO NON-CONFORMING MATERIAL REPORTS ASSOCIATED WITH THIS PRODUCT. A REVIEW OF THE PRODUCT COMPLAINT REPORT HISTORY SHOWS THIS IS THE SECOND COMPLAINT FOR THIS PART NUMBER, ONE DUE TO A SCREW/ASSEMBLY ISSUE. THIS IS THE FIRST COMPLAINT FOR THIS LOT NUMBER. THE ROOT CAUSE FOR THE WORN INSERT WAS NOT DETERMINED WITH CONFIDENCE. THERE IS NO INFORMATION REPORTED THAT SHOWED A MATERIAL, DESIGN, OR MANUFACTURING PROBLEM WITH THE PRODUCT. THERE ARE NO INDICATIONS OF A PRODUCT OR PROCESS ISSUE AFFECTING IMPLANT SAFETY OR EFFECTIVENESS.

Description of Event or Problem · 1

REVISION SURGERY - THE PT HAD SEVERE POSTERIOR WEAR OF THE INSERT COMPONENT, CAUSING IMPINGEMENT AND FLEXION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FOUNDATION KNEE PRIMARY INSERT 11MM CM JWH ENCORE MEDICAL, L.P. 301852

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention